Ubs Group Ag Valneva Se Transaction History
Ubs Group Ag
- $528 Billion
- Q1 2025
A detailed history of Ubs Group Ag transactions in Valneva Se stock. As of the latest transaction made, Ubs Group Ag holds 37 shares of VALN stock, worth $236. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37Holding current value
$236% of portfolio
0.0%Shares
8 transactions
Others Institutions Holding VALN
# of Institutions
15Shares Held
675KCall Options Held
0Put Options Held
0-
General American Investors CO Inc354KShares$2.27 Million0.18% of portfolio
-
Wells Fargo & Company San Francisco, CA243KShares$1.56 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il27.2KShares$174,2010.0% of portfolio
-
Ironwood Investment Management LLC Boston, MA25KShares$160,1400.1% of portfolio
-
Gamma Investing LLC Foster City, CA14KShares$89,3690.01% of portfolio
About Valneva SE
- Ticker VALN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,103,504
- Market Cap $442M
- Description
- Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; ...